Merck & Co – known as MSD outside of the US and Canada – has shared positive results from a late-stage trial of a Keytruda ...

Eli Lilly has announced a $3bn expansion to the US manufacturing facility that it acquired from Nexus Pharmaceuticals earlier ...

Merck & Co – known as MSD outside of the US and Canada – and Ridgeback Biotherapeutics have initiated a late-stage study to ...

Sanofi has presented promising results from a phase 3 study of its investigational oral Bruton’s tyrosine kinase (BTK) ...

Of the patients in the poze-cemdi group, 93% achieved LDH normalisation across study visits on average, compared to 65% of ...

GSK and Rgenta Therapeutics have partnered to develop RNA-targeting small molecule splice modulators for disease areas ...

Did you know we offer a suite of education and training options? Our workshops, insight sessions, and training help Pharma ...

Johnson & Johnson (J&J) has shared positive data from a late-stage study of its subcutaneous CD38-directed antibody Darzalex ...

Novartis will be gaining exclusive global rights to PTC Therapeutics’ mid-stage Huntington’s disease (HD) programme in a deal ...

From animation and gamification, to events, influencers, opinion leaders, and chatbots; there are tools and tactics which can ...

Sanofi has announced plans to invest approximately €1bn to build a new insulin production base in China.

Amgen has announced a $1bn investment to establish a second US drug substance manufacturing facility in North Carolina. The ...